Search results
Showing 2761 to 2775 of 7688 results
Find out more about the diagnostics advisory committee members by reading their biographies. Dr Brian Shine (chair) Biography Brian is a
Biographies and interests register for the indicator advisory committee
Agenda and papers of the NICE public board meeting on 16 December 2022
Agenda and papers of the NICE public board meeting on 27 January 2021
Agenda and papers of the NICE public board meeting on 24 March 2021
Agenda and papers of the NICE public board meeting on 22 March 2023
Agenda and papers of the NICE public board meeting on 19 May 2021
Agenda and papers of the NICE public board meeting on 25 May 2022
Wednesday 17 May 2023 at 1:30pm via Zoom. Agenda Apologies for absence To receive any apologies for absence. Declarations of interest To declare
Our methods and processes (health technology evaluation manual)
Our health technology evaluation manual covers: how we choose medicines and other health technologies to evaluate (topic selection) the steps and...
Costs: charging for technology appraisals and highly specialised technologies
Information about charging for our technology appraisal (TA) and highly specialised technologies (HST) assessments.
Changes to charging for Technology Appraisal and Highly Specialised Technologies consultation
Take part in our consultation: 5 proposals about the way the NICE charges for TAs and HSTs.
Consultation on changes to technology appraisals and highly specialised technologies
NICE and NHS England have launched a 12 week consultation on changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal (TA) and Highly Specialised Technologies (HST) programmes.
Explore data about our technology appraisal guidance
This agreement relates to treating cystic fibrosis patients with: Ivacaftor, tezacaftor and elexacaftor (Kaftrio®) in combination with ivacaftor for